-
1“…However, the first line treatment landscape is not frozen. Two studies (Checkmate-651 and Kestrel) are investigating the efficacy of the combination of antibodies raised against CTLA-4 and PD-(L)1. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto